AstraZeneca to invest $300M in US cell therapy plant
Dive Brief: AstraZeneca, looking to build its presence in cell therapy, plans to invest $300 million in a new manufacturing facility in Rockville, Maryland, that will focus on cancer treatments. The facility will manufacture cell therapies for the company’s clinical trials as well as future commercial supply, the U.K. drugmaker said Tuesday. AstraZeneca expects to […]
AstraZeneca to invest $300M in US cell therapy plant Read More »